INFINITY PHARMACEUTICALS, INC.

Profile

Company Names

INFINITY PHARMACEUTICALS, INC.

Addresses

780 MEMORIAL DRIVE, CAMBRIDGE, MA 02139

Phone Numbers

6174531000

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$78,540,191.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2012-09-07 
$78,540,191.00 
$78,540,191.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JULIAN 
 
ADAMS 
EXECUTIVE OFFICER
INFINITY PHARMACEUTICALS, INC.   |  VEDANTRA PHARMACEUTICALS, INC.   |  ELICIO THERAPEUTICS, INC.   |  ELICIO THERAPEUTICS, INC.
MARTIN 
 
BABLER 
DIRECTOR
INFINITY PHARMACEUTICALS, INC.   |  PRINCIPIA BIOPHARMA INC.   |  ALUMIS INC.
ANTHONY 
B. 
EVNIN 
DIRECTOR
ALTEA THERAPEUTICS CORP   |  CELLADON CORP   |  INFINITY PHARMACEUTICALS, INC.
GWEN 
A. 
FYFE 
DIRECTOR
INFINITY PHARMACEUTICALS, INC.   |  IGENICA INC
STEVE 
H 
HOLTZMAN 
DIRECTOR
INFINITY PHARMACEUTICALS, INC.
ERIC 
S. 
LANDER 
DIRECTOR
INFINITY PHARMACEUTICALS, INC.
PATRICK 
P 
LEE 
DIRECTOR
INFINITY PHARMACEUTICALS, INC.
THOMAS 
J. 
LYNCH 
DIRECTOR
FREDERICK-S OF HOLLYWOOD GROUP INC /NY/   |  INFINITY PHARMACEUTICALS, INC.   |  THERMO FISHER SCIENTIFIC INC.
VITO 
J. 
PALOMBELLA 
EXECUTIVE OFFICER
INFINITY PHARMACEUTICALS, INC.
ADELENE 
Q. 
PERKINS 
EXECUTIVE OFFICER, DIRECTOR
INFINITY PHARMACEUTICALS, INC.
PEDRO 
 
SANTABARBARA 
EXECUTIVE OFFICER
INFINITY PHARMACEUTICALS, INC.
NORMAN 
C. 
SELBY 
DIRECTOR
NANOBIO CORP   |  METAMARK GENETICS, INC.   |  INFINITY PHARMACEUTICALS, INC.   |  KEW GROUP INC.
IAN 
F. 
SMITH 
DIRECTOR
VERTEX PHARMACEUTICALS INC / MA   |  INFINITY PHARMACEUTICALS, INC.
MICHAEL 
C. 
VENUTI 
DIRECTOR
INFINITY PHARMACEUTICALS, INC.   |  WILLOW NEUROSCIENCE, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2012-09-24
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2012-09-07 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#